[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA A Cancer J Clin,2021,71(3):209-249.
[2] ALVAREZ EM,FORCE LM,XU R,et al.The global burden of adolescent and young adult cancer in 2019:a systematic analysis for the Global Burden of Disease Study 2019[J].The Lancet Oncolog,2022,23(1):27-52.
[3] WAKS AG,WINER EP.Breast cancer treatment:a review [J].JAMA,2019,321(3):288-300.
[4] YU W,HURLEY J,ROBERTS D,et al.Exosome-based liquid biopsies in cancer:opportunities and challenges [J].Ann Oncol,2021,32(4):466-477.
[5] VAN NIEL G,D'ANGELO G,RAPOSO G.Shedding light on the cell biology of extracellular vesicles [J].Nat Rev Mol Cell Biol,2018,19(4):213-228.
[6] ROBBINS PD,MORELLI AE.Regulation of immune responses by extracellular vesicles [J].Nat Rev Immunol,2014,14(3):195-208.
[7] OLEJARZ W,KUBIAK-TOMASZEWSKA G,CHRZANOWSKA A,et al.Exosomes in angiogenesis and anti-angiogenic therapy in cancers [J].Int J Mol Sci,2020,21(16):5840.
[8] NOONIN C,THONGBOONKERD V.Exosome-inflammasome crosstalk and their roles in inflammatory responses [J].Theranostics,2021,11(9):4436-4451.
[9] WORTZEL I,DROR S,KENIFIC CM,et al.Exosome-mediated metastasis:communication from a distance [J].Dev Cell,2019,49(3):347-360.
[10] BAI X,NI J,BERETOV J,et al.Cancer stem cell in breast cancer therapeutic resistance [J].Cancer Treat Rev,2018,69:152-163.
[11] XU J,CAMFIELD R,GORSKI SM.The interplay between exosomes and autophagy-partners in crime [J].J Cell Sci,2018,131(15):jcs215210.
[12] TOMASETTI M,LEE W,SANTARELLI L,et al.Exosome-derived microRNAs in cancer metabolism:possible implications in cancer diagnostics and therapy [J].Exp Mol Med,2017,49(1):e285.
[13] SUN Z,YANG S,ZHOU Q,et al.Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment [J].Mol Cancer,2018,17(1):82.
[14] JENA BC,MANDAL M.The emerging roles of exosomes in anti-cancer drug resistance and tumor progression:An insight towards tumor-microenvironment interaction [J].Biochim Biophys Acta Rev Cancer,2021,1875(1):188488.
[15] VALADI H,EKSTRM K,BOSSIOS A,et al.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells [J].Nat Cell Biol,2007,9(6):654-659.
[16] SUN Z.Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment [J].Mol Cancer,2018,17(1):82.
[17] FAN Q,YANG L,ZHANG X,et al.The emerging role of exosome-derived non-coding RNAs in cancer biology [J].Cancer Lett,2018,414:107-115.
[18] HANNAFON B,DING WQ.Intercellular communication by exosome-derived microRNAs in cancer [J].Int J Mol Sci,2013,14(7):14240-14269.
[19] KRISTENSEN LS,ANDERSEN MS,STAGSTED LVW,et al.The biogenesis,biology and characterization of circular RNAs [J].Nat Rev Genet,2019,20(11):675-691.
[20] GUO L,JIA L,LUO L,et al.Critical roles of circular RNA in tumor metastasis via acting as a sponge of miRNA/isomiR [J].Int J Mol Sci,2022,23(13):7024.
[21] KRISTENSEN LS,JAKOBSEN T,HAGER H,et al.The emerging roles of circRNAs in cancer and oncology [J].Nat Rev Clin Oncol,2022,19(3):188-206.
[22] SINHA T,PANIGRAHI C,DAS D,et al.Circular RNA translation,a path to hidden proteome [J].Wiley Interdiscip Rev RNA,2022,13(1):e1685.
[23] WANG Y,WU C,DU Y,et al.Expanding uncapped translation and emerging function of circular RNA in carcinomas and noncarcinomasv [J].Mol Cancer,2022,21(1):13.
[24] KONG S,TAO M,SHEN X,et al.Translatable circRNAs and lncRNAs:Driving mechanisms and functions of their translation products [J].Cancer Lett,2020,483:59-65.
[25] LIN H,YU J,GU X,et al.Novel insights into exosomal circular RNAs:Redefining intercellular communication in cancer biology [J].Clin Transl Med,2021,11(12):e636.
[26] AMICONE L,MARCHETTI A,CICCHINI C.Exosome-associated circRNAs as key regulators of EMT in cancer [J].Cells,2022,11(10):1716.
[27] LI J,ZHANG G,LIU CG,et al.The potential role of exosomal circRNAs in the tumor microenvironment:insights into cancer diagnosis and therapy [J].Theranostics,2022,12(1):87-104.
[28] LI Y,ZHENG Q,BAO C,et al.Circular RNA is enriched and stable in exosomes:a promising biomarker for cancer diagnosis [J].Cell Res,2015,25(8):981-984.
[29] LASDA E,PARKER R.Circular RNAs co-precipitate with extracellular vesicles:a possible mechanism for circrna clearance [J].PLoS One,2016,11(2):e0148407.
[30] RAPOSO G,STOORVOGEL W.Extracellular vesicles:exosomes,microvesicles,and friends [J].J Cell Biol,2013,200(4):373-383.
[31] CHOI D,LEE TH,SPINELLI C,et al.Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation [J].Semin Cell Dev Biol,2017,67:11-22.
[32] KILINC S,PAISNER R,CAMARDA R,et al.Oncogene-regulated release of extracellular vesicles [J].Dev Cell,2021,56(13):1989-2006.
[33] HANNAFON BN,TRIGOSO YD,CALLOWAY CL,et al.Plasma exosome microRNAs are indicative of breast cancer [J].Breast Cancer Res,2016,18(1):90.
[34] JOYCE DP,KERIN MJ.Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer [J].Int J Cancer,2016,139(7):1443-1448.
[35] RODRGUEZ-MARTNEZ A,DE MIGUEL-PREZ D,ORTEGA FG,et al.Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy [J].Breast Cancer Res,2019,21(1):21.
[36] LUO J,XIONG Y,FU PF,et al.Exosomal long non-coding RNAs:biological properties and therapeutic potential in cancer treatment [J].J Zhejiang Univ Sci B,2019,20(6):488-495.
[37] WANG H,SHU L,NIU N,et al.Novel lncRNAs with diagnostic or prognostic value screened out from breast cancer via bioinformatics analyses [J].PeerJ,2022,10:e13641.
[38] WANG J,ZHANG Q,ZHOU S,et al.Circular RNA expression in exosomes derived from breast cancer cells and patients [J].Epigenomics,2019,11(4):411-421.
[39] YANG SJ,WANG DD,ZHOU SY,et al.Identification of circRNA-miRNA networks for exploring an underlying prognosis strategy for breast cancer [J].Epigenomics,2020,12(2):101-125.
[40] LIU J,PENG X,LIU Y,et al.The diagnostic value of serum exosomal has_circ_0000615 for breast cancer patients [J].Int J Gen Med,2021,14:4545-4554.
[41] ZHOU H,HE X,HE Y,et al.Exosomal circRNAs:emerging players in tumor metastasis [J].Front Cell Dev Biol,2021,9:786224.
[42] LIN Q,QI Q,HOU S,et al.Exosomal circular RNA hsa_circ_007293 promotes proliferation,migration,invasion,and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis [J].Bioengineered,2021,12(2):10136-10149.
[43] ZHANG L,ZHANG J,LI P,et al.Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3[J].Cell Death Dis,2022,13(1):32.
[44] ZHOU H,HUANG X,YANG X,et al.CircRAPGEF5 promotes the proliferation and metastasis of lung adenocarcinoma through the miR-1236-3p/ZEB1 axis and serves as a potential biomarker [J].Int J Biol Sci,2022,18(5):2116-2131.
[45] TURCO C,ESPOSITO G,IAIZA A,et al.MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer [J].Commun Biol,2022,5(1):598.
[46] DU WW,LI X,MA J,et al.Promotion of tumor progression by exosome transmission of circular RNA circSKA3[J].Mol Ther Nucleic Acids,2021,27:276-292.
[47] LND F,SUGIYAMA N,BILL R,et al.Distinct contributions of partial and full EMT to breast cancer malignancy [J].Dev Cell,2021,56(23):3203-3221.
[48] CHEN X,CHEN RX,WEI WS,et al.PRMT5 circular rna promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition [J].Clin Cancer Res,2018,24(24):6319-6330.
[49] YANG SJ,WANG DD,ZHONG SL,et al.Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis,metastasis,and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis [J].Cell Death Dis,2021,12(5):420.
[50] LU C,SHI W,HU W,et al.Endoplasmic reticulum stress promotes breast cancer cells to release exosomes circ_0001142 and induces M2 polarization of macrophages to regulate tumor progression [J].Pharmacol Res,2022,177:106098.
[51] YU T,WANG Y,FAN Y,et al.CircRNAs in cancer metabolism:a review [J].J Hematol Oncol,2019,12(1):90.
[52] CHEN T,WANG X,LI C,et al.CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation [J].Oncogene,2021,40(15):2756-2771.
[53] ZHAN Y,DU J,MIN Z,et al.Carcinoma-associated fibroblasts derived exosomes modulate breast cancer cell stemness through exonic circHIF1A by miR-580-5p in hypoxic stress [J].Cell Death Discov,2021,7(1):141.
[54] LIU Y,MA L,HUA F,et al.Exosomal circCARM1 from spheroids reprograms cell metabolism by regulating PFKFB2 in breast cancer [J].Oncogene,2022,41(14):2012-2025.
[55] SHI P,LIU Y,YANG H,et al.Breast cancer derived exosomes promoted angiogenesis of endothelial cells in microenvironment via circHIPK3/miR-124-3p/MTDH axis [J].Cell Signal,2022,95:110338.
[56] ZHOU B,MO Z,LAI G,et al.Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-κB-IL-6 axis of tumor-associated macrophages [J].J Exp Clin Cancer Res,2023,42(1):48.
[57] WANG H,GONG P,CHEN T,et al.Colorectal cancer stem cell states uncovered by simultaneous single-cell analysis of transcriptome and telomeres [J].Adv Sci (Weinh),2021,8(8):2004320.
[58] MEISENBERG C,ASHOUR ME,EL-SHAFIE L,et al.Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan [J].Nucleic Acids Res,2017,45(3):1159-1176.
[59] ADAM-ARTIGUES A,ARENAS EJ,MARTNEZ-SABADELL A,et al.Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer [J].Sci Adv,2022,8(20):eabk2746.
[60] JACKSON LM,DHOONMOON A,HALE A,et al.Loss of MED12 activates the TGFβ pathway to promote chemoresistance and replication fork stability in BRCA-deficient cells [J].Nucleic Acids Res,2021,49(22):12855-12869.
[61] GAO Z,HAN X,ZHU Y,et al.Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling [J].Cell Death Dis,2021,12(5):414.
[62] ZHAO L,LIU W,XIAO J,et al.The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance [J].Cancer Lett,2015,356(2 Pt B):339-346.
[63] CHEN SW,ZHU SQ,PEI X,et al.Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC[J].Mol Cancer,2021,20(1):144.
[64] HU K,LIU X,LI Y,et al.Exosomes mediated transfer of circ_UBE2D2 enhances the resistance of breast cancer to tamoxifen by binding to miR-200a-3p[J].Med Sci Monit,2020,26:e922253.
[65] WU X,REN Y,YAO R,et al.Circular RNA circ-MMP11 contributes to lapatinib resistance of breast cancer cells by regulating the miR-153-3p/ANLN axis [J].Front Oncol,2021,11:639961.
[66] WANG X,CHEN T,LI C,et al.CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR[J].J Hematol Oncol,2022,15(1):122.
[67] SAEEDI S,ISRAEL S,NAGY C,et al.The emerging role of exosomes in mental disorders [J].Transl Psychiatry,2019,9(1):122.
[68] MLLER A,LOBB RJ.The evolving translational potential of small extracellular vesicles in cancer [J].Nat Rev Cancer,2020,20(12):697-709.
[69] CHEN CC,LIU L,MA F,et al.Elucidation of exosome migration across the blood-brain barrier model in vitro [J].Cell Mol Bioeng,2016,9(4):509-529.
[70] BATRAKOVA EV,KIM MS.Using exosomes,naturally-equipped nanocarriers,for drug delivery [J].J Control Release,2015,219:396-405.
[71] ZHANG L,LIANG D,CHEN C,et al.Circular siRNAs for reducing off-target effects and enhancing long-term gene silencing in cells and mice [J].Mol Ther Nucleic Acids,2018,10:237-244.
[72] YI Z,QU L,TANG H,et al.Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo [J].Nat Biotechnol,2022,40(6):946-955.
[73] WESSELHOEFT RA,KOWALSKI PS,ANDERSON DG.Engineering circular RNA for potent and stable translation in eukaryotic cells [J].Nat Commun,2018,9(1):2629.
[74] LI Z,ZHOU X,WEI M,et al.In vitro and in vivo RNA inhibition by CD9-HuR functionalized exosomes encapsulated with miRNA or CRISPR/dCas9[J].Nano Lett,2019,19(1):19-28.
[75] ZHANG PF,GAO C,HUANG XY,et al.Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma [J].Mol Cancer,2020,19(1):110.
[76] LI J,ZHANG G,LIU CG,et al.The potential role of exosomal circRNAs in the tumor microenvironment:insights into cancer diagnosis and therapy [J].Theranostics,2022,12(1):87-104.
[77] HUSSEN BM,MOHAMADTAHR S,ABDULLAH SR,et al.Exosomal circular RNAs:New player in breast cancer progression and therapeutic targets [J].Front Genet,2023,14:1126944.
[78] LI H,PENG K,YANG K,et al.Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies [J].Theranostics,2022,12(14):6422-6436.
[79] XU Z,ZENG S,GONG Z,et al.Exosome-based immunotherapy:a promising approach for cancer treatment [J].Mol Cancer,2020,19(1):160.